United Community Bank Amgen Inc Transaction History

United Community Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $26,275 - $31,931	100 New	100 $31.2 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $25,570 - $28,845	100 New	100 $28.8 Million
Q1 2023 Feb 13, 2024	SELL	$225.79 - $275.2 $128,022 - $156,038	-567 Closed	0 $0
Q2 2022 Feb 13, 2024	SELL	$230.71 - $256.74 $40,374 - $44,929	-175 Reduced 23.58%	567 $138 Million
Q1 2022 Feb 13, 2024	BUY	$219.27 - $242.57 $46,046 - $50,939	210 Added 39.47%	742 $179 Million
Q4 2021 Feb 13, 2024	BUY	$198.88 - $227.6 $105,804 - $121,083	532 New	532 $120 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

Stay updated on United Community Bank with notifications on news.